The U.S. Food and Drug Administration (FDA) recently published a new resource for industry on the new requirement for manufacturers of critical foods, such as infant formula, to develop a redundancy risk management plan.
During World Antimicrobial Awareness Week (November 18–24), the U.S. Department of Agriculture (USDA) released its USDA Strategy to Address Antimicrobial Resistance (AMR) 2023.
The UK Food Standards Agency (FSA) recently published a webpage to guide businesses on the authorization process for cell-cultivated food products in England and Wales.
There is national interest in protecting public health by reducing foodborne illness from Salmonella in poultry. The University of Maryland, in partnership with IAFNS and Structured Partnerships, have been collaborating with USDA-FSIS through a Cooperative Agreement to support data sharing with the aim of reducing Salmonella illnesses in humans.
The European Commission is poised to make the controversial decision to renew ten-year approval of the use of glyphosate, the active ingredient in Monsanto-Bayer’s Roundup product line, which has come under fire in recent years for its association with cancer.
The U.S. Food and Drug Administration (FDA) has updated its Leafy Green STEC Action Plan (LGAP), which outlines the agency’s efforts to reduce foodborne illness outbreaks linked to leafy greens that were caused by Shiga toxin-producing Escherichia coli (STEC).
The Interagency Food Safety Analytics Collaboration (IFSAC)—a joint effort between FDA, CDC, and USDA-FSIS—has published its 2021 report on foodborne illness source attribution for Salmonella, Escherichia coli O157, and Listeria monocytogenes.